Health Care

The stock market shook off an early slump and was mixed in morning trading Tuesday as investors weighed conflicting reports on how the U.S. economy is doing.

The Biotechnology Innovation Organization CEO and former Congressman says drug prices can be lowered by reforming the rebate program.

Tuesday's hearing will likely not be the last congressional appearance by drug executives.

The executives will represent companies with some of the highest-grossing drugs in the world, and have routinely raised prices on many of their products.

Collectively, the executives earned more than $63 million in 2017 while raising the prices on many of their popular drugs.

The deal comes as big pharma rushes to get in on burgeoning gene therapy treatments.

General Electric is selling its biopharma business to Danaher Corp. for $21.4 billion as the industrial giant continues to shed pieces of itself.

General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations.

"Medicare-for-all" can mean different things to different people.

The probe comes as big pharma CEOs prepare to testify in front of the committee.

If you think health care is expensive now, wait until it’s free.

The proposed rules would prevent some ingredients from being sold without a prescription.

'About one out of every thousand kids that get measles is going to die from this, and this is an entirely preventable condition,' the Director of the National Institutes of Health said.

Under the bill, restaurants and stores in California would be banned from selling unsealed “sugar-sweetened beverages" bigger than 16 ounces.

Immune Design's treatments help activate the immune system to produce or expand specific immune cells to fight cancer and other diseases.

Nearly four years ago, the U.S. government's highway safety agency began investigating air bag inflators made by ARC Automotive of Tennessee when two people were hit by flying shrapnel after crashes.

Venezuela's health care system is in a total state of collapse, according to Venezuelan Dr. Jamie Lorenzo

CVS Health is topping fourth-quarter earnings forecasts, but the annual outlook from the nation's second-largest drugstore chain is far short of Wall Street expectations.

The administration's claim could undercut a key argument from the Trump administration.